Letter to the Editor

Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C

Volume 26 · Issue 3 Publish Date: May 15, 2015
Full Text PDF
DOI
Ebubekir Şenateş
Department of Gastroenterology, İstanbul Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey
Yaşar Çolak
Departments of Gastroenterology and Internal Medicine, İstanbul Göztepe Educational and Research Hospital, İstanbul
Atakan Yeşil
Department of Gastroenterology, Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey
İlyas Tuncer
Departments of Gastroenterology and Internal Medicine, Göztepe Training and Research Hospital and Department of Pathology
Şenateş, E., Çolak, Y., Yeşil, A., & Tuncer, İlyas. (2015). Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C. Turkish Journal of Gastroenterology, 26(3), 283–283. https://doi.org/10.5152/tjg.2014.0083
Full Text Full Text PDF

Abstract

Hepatitis C virus (HCV) is a major public health problem and a leading cause of chronic liver disease. Telaprevir is a protease inhibitor used to treat chronic hepatitis C in combination with Peg-interferon (IFN)-α2a+ribavirin (PR) (1); however, it has numerous side effects (2).

Most read articles by the same author(s)

1 2 3 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 26 · Issue 3
Pages 283-283
History
Published Online May 15, 2015
License
Copyright
Affiliations
Ebubekir Şenateş
Department of Gastroenterology, İstanbul Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey
Yaşar Çolak
Departments of Gastroenterology and Internal Medicine, İstanbul Göztepe Educational and Research Hospital, İstanbul
Atakan Yeşil
Department of Gastroenterology, Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey
İlyas Tuncer
Departments of Gastroenterology and Internal Medicine, Göztepe Training and Research Hospital and Department of Pathology
Cite this Article
Şenateş, E., Çolak, Y., Yeşil, A., & Tuncer, İlyas. (2015). Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C. Turkish Journal of Gastroenterology, 26(3), 283–283. https://doi.org/10.5152/tjg.2014.0083
Outlines